Author:
Wei Shu-zhen,Zhan Ping,Shi Mei-qi,Shi Yi,Qian Qian,Yu Li-ke,Song Yong
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference28 articles.
1. Evans T. Chemotherapy in advanced non-small cell lung cancer. Semin Respir Crit Care Med. 2005;26:304–13. doi: 10.1055/s-2005-871989 .
2. Furuta T, Ueda T, Aune G, et al. Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells. Cancer Res. 2002;62:4899–902.
3. Olaussen KA, Dunant A, Fouret P, et al. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med. 2006;355:983–91.
4. Chen J, Larochelle S, Li X, et al. Xpd/Ercc2 regulates CAK activity and mitotic progression. Nature. 2003;424:228–32. doi: 10.1038/nature01746 .
5. Rosell R, Taron M, Ariza A, et al. Molecular predictors of response to chemotherapy in lung cancer. Semin Oncol. 2004;31:20–7. doi: 10.1053/j.seminoncol.2003.12.011 .
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献